RE: Snippet22 May 2026 12:51
Chinese Ai
https://www.dola.com/chat/38413864889357841
Whats the latest progress with the fruitflow (轻络素) health claim and blue cap in China
Latest update (as of 22 May 2026): Fruitflow® (轻络素) is currently under review for a new-function health claim and Blue Hat registration in China, led by By-Health (汤臣倍健). Here is the full status:
📌 Health Claim Progress
International basis: Already approved by EFSA: "Helps maintain normal platelet aggregation, contributing to healthy blood flow".
China filing: Applied as a new health function (not in the original 27 approved categories) — the first such application for cardiovascular-related function in China’s regulatory history.
Status: All domestic clinical trials (on Chinese population) and safety/function verification are completed; technical review is finished, currently awaiting final administrative approval from SAMR (State Administration for Market Regulation). Expected to be approved in Q2–Q3 2026.
Approved wording (expected): "Helps maintain normal platelet aggregation" — cannot mention "prevent thrombosis", "protect blood vessels", or compare to medicine.
🧢 Blue Cap Status
Not yet issued; product has no official Blue Hat mark so far.
Once approved, it will be a registered health food (Big Blue Hat) with a unique registration number, allowing legal sale and functional claim in mainland China.
Will be the first Blue Hat product in China with this specific function.
✅ Key Facts
Ingredient: Water-soluble tomato concentrate, proven to reduce excessive platelet activity by ~9–23%.
Timeline: Started application around 2019; review cycle is long because it is a new function requiring full re-evaluation.
Market impact: Will open a new category for cardiovascular health supplements in China, with strict labeling limits.
Sign In
Follow the stocks
